市場調査レポート
商品コード
1439663
大動脈瘤ステントグラフトの世界市場:洞察、競合情勢、市場予測:2030年Aortic Aneurysm Stent Grafts - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
大動脈瘤ステントグラフトの世界市場:洞察、競合情勢、市場予測:2030年 |
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2~10営業日
|
世界の大動脈瘤ステントグラフトの市場規模は、2024年から2030年までの予測期間中に5.71%のCAGRで拡大すると予測されています。大動脈瘤ステントグラフト市場は、大動脈瘤に罹患する患者の増加、高齢化人口の増加、規制当局の承認の増加、急速な技術開発活動により、プラスの成長が促進されています。さらに、心臓疾患の有病率の増加やこれらのデバイスに対する認知度の高まりが、2024年から2030年までの予測期間中の大動脈瘤ステントグラフト市場の成長に寄与しています。
大動脈瘤ステントグラフト市場は、様々な理由によって製品需要が伸びています。主な要因としては、大動脈瘤の症例が世界的に増加していることが挙げられ、これが製品需要の増加につながり、大動脈瘤ステントグラフトの世界市場に成長機会をもたらしています。
大動脈瘤の発生には喫煙や飲酒などいくつかの危険因子があり、これらは非常に重要です。
大動脈瘤ステントグラフトデバイス市場の成長をもたらすもう1つの主要因は、世界中で高齢者人口が増加していることです。世界保健機関(WHO)が提供したデータによると、2020年には世界中で約10億人が60歳以上になっています。さらに、2050年までに60歳以上の高齢者人口は倍増し、約21億人に達すると予想され、80歳以上の高齢者人口は2020年から2050年の間に3倍に増加し、4億2,600万人に達すると推定されるとしています。加齢は、大動脈瘤などの様々な心臓疾患の発症に関連する主なリスク要因の1つと考えられているため、高齢者人口の増加は、世界中の疾患の患者数の増加につながると予想され、その結果、予測期間(2024年~2030年)における大動脈瘤ステントグラフトデバイスの需要が増加し、大動脈瘤ステントグラフトデバイス市場の成長を促進すると考えられます。
当レポートでは、世界の大動脈瘤ステントグラフト市場について調査し、市場の概要とともに、製品別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。
Aortic Aneurysm Stent Grafts Market By Product (Abdominal Aortic Stent Graft, Thoracic Aortic Stent Graft), By End-User (Hospitals, Ambulatory Surgical Centers, Others), by geography is expected to grow at a steady CAGR forecast till 2030 owing to increasing cases of an aortic aneurysm and rising regulatory approvals
Global Aortic Aneurysm Stent Grafts Market growing at a CAGR of 5.71% during the forecast period from 2024 to 2030. The Aortic Aneurysm Stent Grafts market is witnessing positive growth owing to the increasing cases of patients suffering from aortic aneurysm and the growing aging population, rising regulatory approvals, rapid technological developmental activities. Further, an increase in the prevalence of cardiac diseases and growing awareness of these devices is thereby contributing to the growth of the Aortic Aneurysm Stent Grafts market during the forecast period from 2024-2030.
Aortic Aneurysm Stent Grafts Devices Market Dynamics:
The Aortic Aneurysm Stent Grafts market is witnessing a growth in product demand owing to various reasons. The key factor includes the increasing cases of an aortic aneurysm globally, which leads to more demand for the product, thereby creating growth opportunities for the Global Aortic Aneurysm Stent Grafts Market.
There are several risk factors such as smoking and alcohol consumption, which are very crucial in the development of aortic aneurysms.
As per CDC 2022, a history of smoking accounts for about 75% of all abdominal aortic aneurysms. The U.S. Preventive Services Task Force recommends that men 65 to 75 years old who have ever smoked should get an ultrasound screening for abdominal aortic aneurysms, even if they have no symptoms. In fact, the abdominal aortic aneurysms prevalence is four times higher in smokers than in non-smokers. Hence, early detection is essential for treatment because survival is dependent on the pathway of the disease. This is responsible for the growth of the Global Aortic Aneurysm Stent Grafts Devices market, thereby contributing to the growth of the overall Aortic Aneurysm Stent Grafts Devices market during the forecast period from 2024-2030.
Another key factor responsible for the growth of the Aortic Aneurysm Stent Grafts Devices market is the increasing geriatric population base across the globe. According to the data provided by the World Health Organization, in 2020, about one billion people across the world were over the age of 60. The source further stated that by 2050, the elderly population in the 60 and above age group is expected to double in number representing about 2.1 billion people, and people in the age group of 80 and above are estimated to triple between 2020 and 2050 to reach 426 million. Age is considered as one of the key risk factors associated with the development of various cardiac disorders such as aortic aneurysm, therefore, the rising elderly population is expected to lead to a rise in the patient population of diseases across the world, which in turn would lead to an increase in demand for Aortic Aneurysm Stent Grafts Devices in the forecast period (2024-2030), which will drive the Aortic Aneurysm Stent Grafts Devices market growth.
However, high costs of the treatment and perioperative and postoperative complications like the risk of stent movement and many others may be certain limiting factors of the Aortic Aneurysm Stent Grafts Devices market growth.
The Aortic Aneurysm Stent Grafts Devices market was one of the few markets that reported positive growth during the COVID-19 pandemic. The impact of the COVID-19 pandemic resulted in the surge in revenue for the Aortic Aneurysm Stent Grafts Devices market due to the growing demand among COVID-19-patients. Therefore, the market for Aortic Aneurysm Stent Grafts Devices was expected to witness a positive growth rate during the COVID-19 pandemic.
Aortic Aneurysm Stent Grafts Devices Market Segment Analysis:
Aortic Aneurysm Stent Grafts Devices Market By Product (Abdominal Aortic Stent Graft, Thoracic Aortic Stent Graft), By End-User (Hospitals, Ambulatory Surgical Centers, Others), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the Product segment of the Aortic Aneurysm Stent Grafts Devices market, the Abdominal Aortic Stent Graft is estimated to hold a higher share in the Aortic Aneurysm Stent Grafts Devices market during the forecast period (2024-2030). This can be attributed to the specific features associated with these devices.
The dominance of this segment is owing to the fact that abdominal stent graft therapy is a minimally invasive surgical procedure because it is not necessary to perform open-chest surgery or remove parts of the aorta.
Moreover, the rising research and development activities in the product arena and launch of these devices will also contribute to the growth of the Aortic Aneurysm Stent Grafts Devices market. For instance, on April 08, 2019, Shanghai MicroPort Endovascular MedTech Co., Ltd. obtained a registration certificate for its independently developed Minos(TM) Ultra-Low Profile Abdominal Aortic Aneurysm Stent Graft System from NMPA China.
Furthermore, abdominal aortic aneurysms (AAA) treatment with Abdominal Aortic Stent Graft has gained progressive acceptance owing to better perioperative outcomes than open aortic repair (OAR).
Therefore, considering the advantages associated with Abdominal Aortic Stent Graft, this product category is expected to generate significant revenue share eventually contributing to the overall growth of the global Aortic Aneurysm Stent Grafts Devices market during the forecast period.
North America is expected to dominate the overall Aortic Aneurysm Stent Grafts Devices Market:
Among all the regions, North America is expected to account for the largest share in the Global Aortic Aneurysm Stent Grafts Devices market. Factors such as the rising cases of aortic aneurysms, regulatory approvals, technical improvements, strong financial incentives, are expected to aid in the growth of the North America Aortic Aneurysm Stent Grafts Devices Market during the forecast period of 2024-2030.
The cases of aortic aneurysms are rising constantly in North America. These cases promote the need for use of Aortic Aneurysm Stent Grafts in disease treatments. For instance, as per CDC 2022, aortic aneurysms or aortic dissections were the cause of 9,904 deaths in 2019. In 2019, about 59% of deaths due to aortic aneurysm or aortic dissection occurred among menin United States.
Another factor responsible for the growth of the Aortic Aneurysm Stent Grafts Devices market is the rising regulatory product approvals of innovative devices. For instance, on May 11, 2022, Endologix LLC had announced the launch and first implant of its ALTO® Abdominal Stent Graft in Canada following recent approval from Health Canada.
In May 2020, Terumo Aortic announced the US Food and Drug Administration (FDA) approval of the TREO(TM) Abdominal Aortic Stent-Graft System for sale in the United States for the treatment of patients with abdominal aortic aneurysms (AAA).
These kinds of product launches in the local markets may drive the product demand in the market. The rising adoption of Aortic Aneurysm Stent Grafts Devices in the country would result in the rising demand for treatments that make use of Aortic Aneurysm Stent Grafts, which in turn would provide a conducive growth environment for the United States Aortic Aneurysm Stent Grafts Devices market as well as the North American region. Therefore, the interplay of various factors such as the presence of a large patient population, encouraging reimbursement policies as well as the new product launches in the region is expected to boost the North America Aortic Aneurysm Stent Grafts Devices market during the forecast period.
Aortic Aneurysm Stent Grafts Devices Market Key Players:
Some of the key market players operating in the Aortic Aneurysm Stent Grafts Devices market include Medtronic, Terumo, Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd. (MicroPort Scientific Corporation), Cook, Cordis, JOTEC GmbH, W. L. Gore & Associates, Inc., Endologix LLC, Lombard Medical, Lifetech Scientific, SB-Kawasumi Laboratories, Inc., Endospan, and others.
Recent Developmental Activities in the Aortic Aneurysm Stent Grafts Devices Market:
On August 18, 2020, Endospan had received investigational device exemption (IDE) approval from the US Food and Drug Administration (FDA) to start the TRIOMPHE study on the NEXUS Aortic Arch Stent Graft System.
In September 2019, cardiac and vascular surgery company CyroLife Inc. signed a distribution agreement, credit facilities, and option agreement to acquire Israel-based stent-graft company EndoSpan Ltd. EndoSpan develops stent graft systems for treating aneurysms and dissections throughout the aorta.
Key Takeaways from the Aortic Aneurysm Stent Grafts Devices Market Report Study
Target Audience who can be benefited from this Aortic Aneurysm Stent Grafts Devices Market Report Study
Frequently Asked Questions for Aortic Aneurysm Stent Grafts Devices Market:
Aortic Aneurysm Stent Grafts are devices placed inside the abdominal aorta or thoracic aorta to help protect the aneurysm from rupturing. The stent graft is placed inside the aneurysm with the help of a long, very thin, soft, plastic tube called a delivery catheter.
Global Aortic Aneurysm Stent Grafts Market growing at a CAGR of 5.71% during the forecast period from 2024 to 2030.
The Aortic Aneurysm Stent Grafts Devices market is witnessing a positive market growth owing to the increasing cases of an aortic aneurysm and the growing aging population, rising regulatory approvals, rapid technological developmental activities. Further, an increase in the prevalence of cardiac diseases due to smoking and alcohol consumption and growing awareness of these devices is thereby contributing to the growth of the Aortic Aneurysm Stent Grafts market.
Some of the key market players operating in the Aortic Aneurysm Stent Grafts Devices market include Medtronic, Terumo, Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd. (MicroPort Scientific Corporation), Cook, Cordis, JOTEC GmbH, W. L. Gore & Associates, Inc., Endologix LLC, Lombard Medical, Lifetech Scientific, SB-Kawasumi Laboratories, Inc., Endospan, and others.
North America is expected to hold the highest share in the revenue in the Aortic Aneurysm Stent Grafts Devices market during the forecast period. Factors such as the rising cases of aortic aneurysms, regulatory approvals, technical improvements, strong financial incentives, are expected to aid in the growth of the North America Aortic Aneurysm Stent Grafts Devices Market in this region.